Treg depletion attenuates the severity of skin disease from ganglionic spread after HSV-2 flank infection

Virology

Volumn 447, Issue 1-3, 2013, Pages 9-20

  Fernandez, Marian A ^a,b   Yu, Uet ^a,b   Zhang, Geoff ^a   White, Rose ^a,b   Sparwasser, Tim ^c   Alexander, Stephen I ^a,b   Jones, Cheryl A ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

Author keywords

Chemokine; Flank infection; Ganglia; Herpes simplex virus; Mice; Regulatory T cells; Skin

Indexed keywords

CHEMOKINE; GRANULOCYTE RECEPTOR 1; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG; VASCULOTROPIN A; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GANGLION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; LYMPH NODE; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; REGULATORY T LYMPHOCYTE; SKIN DISEASE;

CHEMOKINE; FLANK INFECTION; GANGLIA; HERPES SIMPLEX VIRUS; MICE; REGULATORY T CELLS; SKIN;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; GANGLIA; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; LEUKOCYTE REDUCTION PROCEDURES; LYMPHOCYTES; MICE; MICE, INBRED C57BL; SKIN; SKIN DISEASES, VIRAL; T-LYMPHOCYTES, REGULATORY;

EID: 84884313855     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.08.027     Document Type: Article

References (54)

1. + regulatory T cells and limited effect of T cell-derived IL-10 on pathogen clearance during Plasmodium yoelii infection. J. Immunol. (Baltimore, Md: 1950) 2012, 188:5467-5477.
2. 2 recombinant herpes simplex virus vector results in expression of MHC class I antigens on the surfaces of human neuroblastoma cells in vitro and mouse sensory neurons in vivo. J. Gen. Virol. 2000, 81:2375-2383.
3. Berod L., Puttur F., Huehn J., Sparwasser T. Tregs in infection and vaccinology: heroes or traitors?. Microb. Biotechnol. 2012, 5:260-269.
4. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
5. Donaghy H., Bosnjak L., Harman A.N., Marsden V., Tyring S.K., Meng T.C., Cunningham A.L. Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection. J. Virol. 2009, 83:1952-1961.
6. Eidsmo L., Stock A.T., Heath W.R., Bedoui S., Carbone F.R. Reactive murine lymph nodes uniquely permit parenchymal access for T cells that enter via the afferent lymphatics. J. Pathol. 2012, 226:806-813.
7. Evans I.A., Jones C.A. Maternal immunization with a herpes simplex virus type 2 replication-defective virus reduces visceral dissemination but not lethal encephalitis in newborn mice after oral challenge. J. Infect. Dis. 2002, 185:1550-1560.
8. Evans I.A., Jones C.A. HSV induces an early primary Th1 CD4 T cell response in neonatal mice, but reduced CTL activity at the time of the peak adult response. Eur. J. Immunol. 2005, 35:1454-1462.
9. + T cell responses to herpes simplex virus type 2 in neonatal mice. J. Immunol. (Baltimore, Md: 1950) 2008, 180:1556-1564.
10. + T cells are slow to develop into lytic effectors after HSV infection in vivo. Eur. J. Immunol. 2008, 38:102-113.
11. Field HJ, Vere Hodge RA Recent developments in anti-herpesvirus drugs. Br. Med. Bull. 2013, 106:213-249.
12. Jones C.A., Taylor T.J., Knipe D.M. Biological properties of herpes simplex virus 2 replication-defective mutant strains in a murine nasal infection model. Virology 2000, 278:137-150.
13. Josefowicz S.Z., Lu L.F., Rudensky A.Y. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 2012, 30:531-564.
14. Kim J.O., Cha H.R., Kim E.D., Kweon M.N. Pathological effect of IL-17A-producing TCRgammadelta(+) T cells in mouse genital mucosa against HSV-2 infection. Immunol. Lett. 2012, 147:34-40.
15. Kosz-Vnenchak M., Jacobson J., Coen D.M., Knipe D.M. Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons. J. Virol. 1993, 67:5383-5393.
16. Kramer M., Riley J., Spoering A., Coen D., Knipe D. Effect of immunization on herpes simplex virus type 1 latent infection in the trigeminal ganglion. Curr. Eye Res. 2003, 26:185-194.
17. + regulatory T cells induces a scurfy-like disease. J. Exp. Med. 2007, 204:57-63.
18. + T cells into the nervous system following ocular herpes simplex virus-1 infection. J. Immunol. (Baltimore, Md: 1950) 2005, 174:2919-2925.
19. Lee A.J., Ashkar A.A. Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development. Curr. Opin. Infect. Dis. 2012, 25:92-99.
20. + T cells can clear established lytic infections from skin and nerves and can partially limit the early spread of virus after cutaneous inoculation. J. Immunol. (Baltimore, Md: 1950) 2004, 172:392-397.
21. Loebbermann J., Thornton H., Durant L., Sparwasser T., Webster K.E., Sprent J., Culley F.J., Johansson C., Openshaw P.J. Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. Mucosal Immunol. 2012, 5:161-172.
22. Loser K., Mehling A., Apelt J., Stander S., Andres P.G., Reinecker H.C., Eing B.R., Skryabin B.V., Varga G., Schwarz T., Beissert S. Enhanced contact hypersensitivity and antiviral immune responses in vivo by keratinocyte-targeted overexpression of IL-15. Eur. J. Immunol. 2004, 34:2022-2031.
23. Lubinski J.M., Lazear H.M., Awasthi S., Wang F., Friedman H.M. The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo. J. Virol. 2011, 85:3239-3249.
24. Lund J.M., Hsing L., Pham T.T., Rudensky A.Y. Coordination of early protective immunity to viral infection by regulatory T cells. Science (New York, NY) 2008, 320:1220-1224.
25. Maertzdorf J., Osterhaus A.D., Verjans G.M. IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts. J. Immunol. (Baltimore, Md: 1950) 2002, 169:5897-5903.
26. Maizels R.M., Smith K.A. Regulatory T cells in infection. Adv. Immunol. 2011, 112:73-136.
27. Matsushima H., Takashima A. Bidirectional homing of Tregs between the skin and lymph nodes. J. Clin. Invest. 2010, 120:653-656.
28. Molesworth-Kenyon S.J., Yin R., Oakes J.E., Lausch R.N. IL-17 receptor signaling influences virus-induced corneal inflammation. J. Leukoc. Biol. 2008, 83:401-408.
29. Molesworth-Kenyon S.J., Popham N., Milam A., Oakes J.E., Lausch R.N. Resident corneal cells communicate with neutrophils leading to the production of IP-10 during the primary inflammatory response to HSV-1 infection. Int. J. Inflammation 2012, 2012:810359.
30. Puttur F.K., Fernandez M.A., White R., Roediger B., Cunningham A.L., Weninger W., Jones C.A. Herpes simplex virus infects skin gamma delta T cells before Langerhans cells and impedes migration of infected Langerhans cells by inducing apoptosis and blocking E-cadherin downregulation. J. Immunol. (Baltimore, Md: 1950) 2010, 185:477-487.
31. + regulatory T cells control persistence of viral CNS infection. PLoS One 2012, 7:e33989.
32. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 2004, 22:531-562.
33. Sehrawat S., Rouse B.T. Tregs and infections: on the potential value of modifying their function. J. Leukoc. Biol. 2011, 90:1079-1087.
34. Sheridan P.A., Beck M.A. The dendritic and T cell responses to herpes simplex virus-1 are modulated by dietary vitamin E. Free Radical Biol. Med. 2009, 46:1581-1588.
35. Simmons A., Nash A.A. Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. J. Virol. 1984, 52:816-821.
36. Simmons A., Tscharke D.C. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J. Exp. Med. 1992, 175:1337-1344.
37. Spang A.E., Godowski P.J., Knipe D.M. Characterization of herpes simplex virus 2 temperature-sensitive mutants whose lesions map in or near the coding sequences for the major DNA-binding protein. J. Virol. 1983, 45:332-342.
38. + T cell repertoire in C57BL/6 mice. J. Immunol. (Baltimore, Md: 1950) 2011, 186:3927-3933.
39. + regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice. Hepatology (Baltimore, Md) 2012, 56:873-883.
40. Suryawanshi A., Veiga-Parga T., Rajasagi N.K., Reddy P.B., Sehrawat S., Sharma S., Rouse B.T. Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. J. Immunol. (Baltimore, Md: 1950) 2011, 187:1919-1930.
41. + T cell responses. J. Exp. Med. 2003, 198:889-901.
42. + regulatory T cells control the severity of viral immunoinflammatory lesions. J. Immunol. (Baltimore, Md: 1950) 2004, 172:4123-4132.
43. Sydiskis R.J., Schultz I. Herpes simplex virus infection in mice. J. Infect. Dis. 1965, 115:237-246.
44. Thompson R.L., Sawtell N.M. Replication of herpes simplex virus type 1 within trigeminal ganglia is required for high frequency but not high viral genome copy number latency. J. Virol. 2000, 74:965-974.
45. Veiga-Parga T., Suryawanshi A., Rouse B.T. Controlling viral immuno-inflammatory lesions by modulating aryl hydrocarbon receptor signaling. PLoS Pathog. 2011, 7:e1002427.
46. Veiga-Parga T., Suryawanshi A., Mulik S., Gimenez F., Sharma S., Sparwasser T., Rouse B.T. On the role of regulatory T cells during viral-induced inflammatory lesions. J. Immunol. (Baltimore, Md: 1950) 2012, 189:5924-5933.
47. Wang E.E., Lubinski F., Bunte J.M., Friedman R.M. HM: a replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine. J. Virol. 2008, 82:8431-8441. (Brittle).
48. Wang F., Zumbrun E.E., Huang J., Si H., Makaroun L., Friedman H.M. Herpes simplex virus type 2 glycoprotein E is required for efficient virus spread from epithelial cells to neurons and for targeting viral proteins from the neuron cell body into axons. Virology 2010, 405:269-279.
49. + regulatory T cells induced by T cell vaccination protect against autoimmune nephritis. J. Am. Soc. Nephrol.: JASN 2012, 23:1058-1067.
50. Weeks B.S., Alston N.I., Cadet P., Zhu W., Rialas C., Stefano G.B. Morphine reduces herpes simplex virus-1 pathogenesis in the murine flank. Int. J. Mol. Med. 2001, 8:303-307.
51. + cells, but not neutrophils, limit virus replication and lesion development following flank infection of mice with herpes simplex virus type-1. Virology 2010, 407:143-151.
52. +, immune cells exacerbates virus replication and disease in an intranasal model of herpes simplex virus type 1 infection. J. Gen. Virol. 2010, 91:2158-2166.
53. + T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J.Exp. Med. 2007, 204:595-603.
54. Zhu J., Hladik F., Woodward A., Klock A., Peng T., Johnston C., Remington M., Magaret A., Koelle D.M., Wald A., Corey L. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat. Med. 2009, 15:886-892.